Call us
Thymosin Alpha-1

Thymosin Alpha-1

Thymosin alpha-1 is a small protein, 28-amino acid peptide produced by the thymus gland. Thymosin alpha-1 can increase T-cell and dendritic cell (DC) responses, as well as antibody responses. It can also regulate chemokines and cytokines production and deter steroid-induced apoptosis. Thymosin alpha-1 is part of thymosin fraction 5, which restores immune function in animals that lack thymus glands. Its 28-amino acid peptide fragment originates from an extensive 113-amino acid precursor, prothymosin alpha. Studies have shown it may boost cell-mediated immunity, and may be a possible treatment option for Hepatitis B and C, and may increase immunity against other diseases. The primary function of thymosins in general is the regulation and adjustment of biological responses.

Some Potential Benefits:

  • Destroys Unhealthy Cells to Stop Infection or Cancer Growth
  • Suppresses Tumor Growth
  • Improves Vaccine Effectiveness
  • Enhances Function of T-Cells and Dendritic Cells
  • Antibacterial Properties
  • Antifungal Properties
  • Protects Against Potential Oxidative Damage

Other Possible Uses/Treatment of:

  • TB
  • Peritonitis
  • Acute Cytomegalovirus Infection
  • Chronic Hepatitis B
  • Severe Acute Respiratory Syndrome
  • Lung Infections in Critically Ill Patients
  • Septic Shock
  • Acute Respiratory Distress Syndrome

Dosing

Thymosin alpha-1 is typically delivered in single-use vials of 1.6 mg of lyophilized product. Reconstitution is necessary before use. Reconstitute with 1ml of sterile water. Thymosin alpha-1 is designed to be administered via subcutaneous injection. Do not administer intravenously.

  • "It is rare to find health professionals who are so willing to educate the patient on what they need to know."

    Clair C. | West Hollywood, CA